Ashley W. Tiegs, MD, FACOG, TS (ABB)

About

The question behind Ashley Tiegs’s signature study is one patients ask constantly: when a PGT-A biopsy labels an embryo aneuploid, how much should you trust the label? Her multi-center, prospective, blinded, non-selection study evaluated the predictive value of an aneuploid PGT-A result and what a biopsy actually tells you — work that carried her through national and international recognition: the Fertility & Sterility 2021 Investigator Achievement Award, the 2020 Society for Reproductive Investigation President’s Presenter Award, and the 2019 ASRM Corporate Member Council In-Training Award. She has since published more than 15 peer-reviewed papers on assisted reproductive technologies, embryology, and male and female infertility factors.

Tiegs grew up in Atlanta. She did college and medical school at Wake Forest, residency in obstetrics and gynecology at NYU, then REI fellowship at Jefferson-RMA before joining ACRM — now branded CCRM Fertility of Atlanta — in the summer of 2020. In her welcoming statement she singled out the practice’s embryology lab as “undoubtedly vital to their success”; embryo culture and IVF remain first on her list of clinical interests.

Her stated interests otherwise map onto exactly the decisions modern IVF forces: PGT-A, male factor infertility, recurrent pregnancy loss, third-party reproduction, and fertility preservation. A goal she names plainly is heightening awareness that infertility is common — and giving patients options, hope, and results rather than one of the three.

Clinical Expertise

• PGT-A interpretation: the predictive value of aneuploidy testing was her landmark study; she is the in-house answer to “should we trust this biopsy result?”
• Embryo culture and IVF: lab-side decisions inside the CCRM Atlanta embryology program
• Male factor infertility: listed among her research and clinical publication areas
• Recurrent pregnancy loss: evaluation and next-step planning
• Third-party reproduction: donor eggs, donor sperm and gestational carrier cycles
• Fertility preservation: egg and embryo freezing for planned delay or medical need

Why Choose Dr. Tiegs

She wrote the study, not just the protocol. Few private-practice physicians in a 2020 hire have an award-winning multi-center PGT-A paper at their backs; she has three national and international awards on the same body of work (2019, 2020, 2021).

Fifteen-plus publications by her fifth Atlanta year — a research output in ART, embryology and both partners’ infertility factors that most clinic websites can only gesture at.

Third-party reproduction is a named interest, so donor-egg, donor-sperm and gestational carrier plans sit inside one physician’s stated focus rather than a general “we do that too.”

Professional Affiliations

Fellow of the American College of Obstetricians and Gynecologists (FACOG); member of the American Society for Reproductive Medicine. The practice’s profile also lists the PCRS professional training fellowship, an ACOG John Gibbons award from her Wake Forest medical-school years, and obstetrics and gynecology honors at Wake Forest. Recognition since joining: Castle Connolly Rising Star 2022-2024, Castle Connolly Top Doctor 2025, Atlanta Magazine Top Doctor 2024.

Suitable For

• Patients deciding whether to do PGT-A: the physician who researched what the test’s results really predict
• Diminished ovarian reserve: where embryo selection decisions are hardest and trust in biopsy data matters most
• Donor egg, donor sperm and gestational carrier families: third-party reproduction as a stated focus
• Repeated loss or failed transfers: recurrent pregnancy loss plus recurrent implantation questions, backed by the publications